Recent studies demonstrated that SLC1A5, the primary glutamine transporter, could promote tumor cell growth, cell cycle progression and survival in neuroblastoma, colorectal cancer, breast cancer and prostate cancer19, 20, 21, 22. This evidence concerns the gene SLC1A5 and colorectal cancer.